Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Assessing comparative effectiveness of new drugs before approval using prospective network meta-analyses

16 references·2 citing·37 second hop

FromToDepth

this work references cited by second hop

References

2010Checking consistency in mixed treatment comparison meta‐analysis2,517 cited
2004Combination of direct and indirect evidence in mixed treatment comparisons2,168 cited
2000Methods for Meta-Analysis in Medical Research1,795 cited
2012Evidence Synthesis for Decision Making 21,206 cited
2002Network meta‐analysis for indirect treatment comparisons1,204 cited
2012Consistency and inconsistency in network meta‐analysis: model estimation using multivariate meta‐regression1,114 cited
2011Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 11,036 cited
1994Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated1,016 cited
2003Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses944 cited
2011Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2770 cited
2011NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials555 cited
2009Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews395 cited
2009

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

302 cited

2009Addressing between‐study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non‐rheumatic atrial fibrillation237 cited

2010A Review of Quantitative Risk–Benefit Methodologies for Assessing Drug Safety and Efficacy—Report of the ISPOR Risk–Benefit Management Working Group202 cited

2011Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study200 cited

Cited by

2020Generating comparative evidence on new drugs and devices after approval87 cited
2020Generating comparative evidence on new drugs and devices before approval79 cited